Zhen-qiang Pan
Takhar Kasumov
Robin Ketteler
Robert Tomko
Robert Blake
Paola Castaldi
Paola Castaldi is the Director and global Head of Chemical Biology & Proteomics at AstraZeneca. Her team is focused on supporting drug discovery programs across all therapeutics areas using state of the art technologies with specific emphasis on target identification, target engagement, MoA and off-target determination. Paola has played a critical role to establish a multi-omics and a therapeutic protein degradation platform at AstraZeneca providing both strategic and logistics directions. Before AstraZeneca, Paola was a key contributor of the Chemical Genetics group at Sanofi Oncology, Cambridge, MA with a focus on phenotypic drug discovery projects for the Wnt and KRAS oncogenic pathways. Prior to Sanofi Paola was at Makoto Life Sciences, where she was responsible for the chemistry strategies towards the identification of the PRPK/TPRKB complex as validated biological targets of immunomodulatory drugs that include lenalidomide (Revlimid), pomalidomide (Pomalyst) and thalidomide implicated in multiple myeloma. Paola Castaldi completed her undergraduate studies in pharmaceutical chemistry and received her Laurea (MSc) at University of Padova, Italy. She then went on to conduct graduate research studies at Imperial College London, UK and postdoctoral studies at UCSD and Boston University.
Something people may not know about her:
Paola is a mother of a 7-year-old girl and 9 years old boy and she loves travelling around the world with her family!!
--Paola practices heated power yoga to maintain focus and peace in her “crazy” daily life--
Nello Mainolfi
Fiona Davies
Fiona previously worked in the wine industry within Aldi’s award-winning buying team. She moved into category management at Holland & Barrett in October 2018 and spearheaded the alcohol free proposition, sourcing new and innovative suppliers with the intention of offering customers an exciting mix of quality alcohol free options on the high street. The range launched in July 2019 and is growing in success, accounting for 50% of the total ‘free from’ category sales.
